Volume 33, No 11, Nov 2023

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 33 Issue 11, November 2023: 887-890

LETTERS TO THE EDITOR

Development of a highly-efficient erythrocyte-drug covalent conjugation platform and its use in treating thrombotic disorders

Yanjie Huang^1,2,3,4,† , Xiaoqian Nie^1,2,3,4,† , Xuewen Liu^1,2,3,4,† , Yuehua Liu^2,3,4,5 , Huifei Yu⁶ , Xiaofei Gao^2,3,4,*

¹School of Basic Medical Sciences, Fudan University, Shanghai, China
²Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China
³Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China
⁴Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China
⁵College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China
⁶Westlake Therapeutics, Inc., Hangzhou, Zhejiang, China
^†These authors contributed equally: Yanjie Huang, Xiaoqian Nie, Xuewen Liu
Correspondence: Xiaofei Gao(gaoxiaofei@westlake.edu.cn)

https://doi.org/10.1038/s41422-023-00868-2

FULL TEXT | PDF

Browse 530